Hypertension Diagnostics, Inc. (HDII)
- Previous Close
0.0002 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0001 - 0.0045 - Volume
53,180 - Avg. Volume
1,593 - Market Cap (intraday)
56,956 - Beta (5Y Monthly) -2.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.
www.hypertensiondiagnostics.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: HDII
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HDII
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HDII
Valuation Measures
Market Cap
56.96k
Enterprise Value
56.96k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.02
Enterprise Value/EBITDA
0.79
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.31%
Return on Assets (ttm)
0.03%
Return on Equity (ttm)
--
Revenue (ttm)
3.79M
Net Income Avi to Common (ttm)
-125.39k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
5.66k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-432k